期刊文献+

大鼠血浆中白藜芦醇衍生物(BTM-0512)药代动力学研究 被引量:4

Pharmacokinetic studies of resveratrol derivative(BTM-0512)in rat plasma
下载PDF
导出
摘要 目的:建立 RP-HPLC 法测定大鼠血浆中白藜芦醇衍生物3,5,4'-O-三甲基白藜芦醇(BTM-0512)浓度的方法并进行药代动力学研究,为该化合物的进一步开发提供实验依据。方法:取血浆样品,以乙腈沉淀蛋白,用 Hypersil C_(18)柱(5 μm,250 mm×4.6 mm)分离,己烯雌酚为内标,乙腈-水(65:35)为流动相,流速1.0 mL·min^(-1),检测波长319 nm。结果:BTM-0512的线性范围为0.01~10.0μg·mL^(-1),r>0.999;日内、日间精密度 RSD 小于10.0%;相对回收率在98.2%~101.3%之间,最低检出限为0.005μg·mL^(-1),最低定量限为0.01μg·mL^(-1)。结论:本方法灵敏度高,操作简便、准确,经方法学确证和稳定性评价,可用于大鼠血浆中 BTM-0512的测定及药代动力学研究。 Objective:To develop an RP - HPLC method for the determination of resveratrol derivative 3,5,4′ - O -trimethylresveratrol (BTM -0512) in rat plasma and to study the pharmacokinetic profile of BTM -0512 in rats. Method:Plasma samples were treated with acetonitrile to deposit proteins, and samples were then analyzed by HPLC on a Hypersil C18 column ( 5μm,250 mm× 4.6 mm) using a acetonitrile - water ( 65: 35 ) mixture solvent as the mobile phase at a flow rate of 1 mL · min^-1. The column effluent was monitored by UV detector at 319 nm and diethylstilbestrol was used as the internal standard. Results:Calibration curves of 3,5,4′ - O - trimethylresveratrol in rat plasma at concentrations ranging from 0.01 to 10.0 μg · mL^-1 were excellent linearity with intra - and inter - day precision of RSD 〈 10. 0% and accuracy in the range 98.2% - 101.3%. The lower limit of detection and quantification were 0. 005 μg · mL^-1 and 0.01 μg · mL^-1 , respectively, in plasma. Conclusion: The validated method is quick, accurate, and has been successfully applied to study the pharmacokinetic characteristics of BTM - 0512 in rats.
出处 《药物分析杂志》 CAS CSCD 北大核心 2008年第9期1413-1417,共5页 Chinese Journal of Pharmaceutical Analysis
关键词 3 5 4′-O-三甲基白藜芦醇 大鼠血浆 药代动力学 生物利用度 3,5,4′ - O - trimethylresveratrol rat plasma pharmacokinetics bioavailability
  • 相关文献

参考文献18

  • 1Hain R, Reif H J, Krause E, et al. Disease resistance results from foreign phytoalexin expression in a novel plant. Nature, 1993, 361 (6408) :153
  • 2Filip V, Plockova M, Smidrkal J, et al. Resveratrol and its antioxidant and antimierobial effectiveness. Food Chem ,2003 ,83 (4) :585
  • 3Pace- Asciak CR, Hahn S, Diamandis EP, et al. The red wine phenolics trans - resveratrol and quercetin block human platelet aggregation and eicosanoid synthesis:Implications for protection against coronary heart disease. Clin Chim Acta,1995,235(2) :207
  • 4Luzi C, Brisdelli F, Cinque B, et al. Differential sensitivity to resveratrol - induced apoptosis of human chronic myeloid(K562) and acute lymphoblastic ( HSB - 2 ) leukemia cells. Biochem Pharmacol, 2004, 68(10) :2019
  • 5Mertens - Talcott SU, Percival SS. Ellagic acid and quercetin interact synergistically with resveratrol in the induction of apoptosis and cause transient cell cycle arrest in human leukemia cells. Cancer Lett ,2005,218 (2) : 141
  • 6Chabert, P, Fougerousse A, Brouillard R. Anti - mitotic properties of resveratrol analog ( Z ) - 3,5,4' - trimethoxystilbene. Biofactors, 2006,27( 1 -4) :37
  • 7Schneider Y, Chabert P, Stutzmann J, et al. Resveratrol analog (Z) -3,5,4' -trimethoxystilbene is a potent anti -mitotic drug inhibiting tubulin polymerzation, Int J Cancer,2003,107 (2) :189
  • 8Sale S, Verschoyle RD, Boocock D, et al. Pharmacokinetics in mice and growth - inhibitory properties of the putative cancer chemopreventive agent resveratrol and the synthetic analogue trans 3,4,5,4' - tetramethoxystilbene. Br J Cancer, 2004,90 ( 3 ) :736
  • 9Ugo A, Giovanna D, Maria VI, et al. Regioselective reduetive demethoxylation of 3,4,5 - trimethoxystilbenes. Tetrahedron,2003,59:7961
  • 10Daniele S, Marinella R, Francesco PI, et al. Stilbene - based anticancer agents :Resveratrol analogues active toward HL60 leukemic cells with a non - specific phase mechanism. Bioorg Med Chem Lett ,2006 ,16 :3245

二级参考文献17

  • 1Cao Y, Cao R, Brakenhielm E. Antiangiogenic mechanisms of diet-derived polyphenols [ J ]. J Nutr Biochem, 2002,13:380 - 390.
  • 2Jang M, Cai L, Udeani GO, et al. Cancer chemopreventive activity of resveratrol, a natural product derived from grapes [ J ]. Science, 1997,275:218 - 220.
  • 3Belleri M, Ribatti D, Nicoli S, et al. Antiangiogenic and vascular-targeting activity of the microtubule destabilizing trans-resveratrol derivative 3, 5, 4'-trimethoxystilbene [J]. Mol Pharmacol, 2005,67 : 1451 - 1459.
  • 4Chabert P, Fougerousse A, Brouillard R. Anti-mitotic properties of resveratrol analog ( Z )-3, 5, 4'- trimethoxystilbene [ J ]. Biofactors, 2006,27:37 - 46.
  • 5Cushman M, Nagarathnam D, Gopal D, et al. Synthesis and evaluation of analogues of ( Z )-1-( 4- methoxyphenyl ) -2-( 3,4,5-trimethoxyphenyl ) ethene as potential cytotoxic and antimitotic agents [J]. J Med Chem, 1992,35:2293 - 2306.
  • 6Simoni D, Roberti M, lnvidiata FP, et al. Stilbene-based anticancer agents: resveratrol analogues active toward HL60 leukemic cells with a non-specific phase mechanism [J]. Bioorg Med Chem Lett, 2006,16:3245-3248.
  • 7Matsuda H, Tewtrakul S, Morikawa T, et al. Antiallergic activity of stilbenes from Korean rhubarb ( Rheum undulatum L. ) : structure requirements for inhibition of antigen-induced degranulation and their effects on the release of TNF-a and IL-4 in RBL-2H3 cells [ J ]. Bioorg Med Chem, 2004,12:4871 - 4876.
  • 8Kim S, Ko H, Park JE, et al. Design, synthesis, and discovery of novel trans-stilbene analogues as potent and selective human cytochrome P450 1B1 inhibitors [ J ]. J Med Chem, 2002,45 : 160 - 164.
  • 9Pettit GR, Grealish MP, Jung MK, et al. Antineoplastic agents. 465. Structural modification of resveratrol: sodium resverastatin phosphate [ J ]. J Med Chem, 2002, 45:2534 - 2542.
  • 10Sale S, Verschoyle RD, Boocock D, et al. Pharmacokinetics in mice and growth-inhibitory properties of the putative cancer chemopreventive agent resveratrol and the synthetic analogue trans 3, 4, 5, 4'- tetramethoxystilbene [ J ]. Br J Cancer, 2004,90:736 - 744.

共引文献3

同被引文献2003

引证文献4

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部